CBD Class-Action Litigants Watching For Retroactive Effects In US FDA’s Awaited Rulemaking – HBW Insight December 23, 2020 No Comments CBD Class-Action Litigants Watching For Retroactive Effects In US FDA’s Awaited Rulemaking HBW Insight * This article was originally published here Tags: cannabis, investments